LRP6 and hepatocellular carcinoma: However, in contrast to our findings, Nan et al. reported that miR-432 inactivated the Wnt/β-catenin pathway by simultaneously inhibiting the expression of LRP6, TRIM29, and Pygo2, thereby inhibiting the proliferation of human hepatocellular carcinoma [80].